Business law

PJSC RusHydro: Results of the Board of Directors Meeting on July 29, 2021

Articles, Committees, Corporate law, Business, Board of directors, Business law, RusHydro, Audit committee, Chairperson
Friday, July 30, 2021 - 6:52pm

Results of the Board of Directors Meeting on July 29, 2021

Key Points: 
  • Results of the Board of Directors Meeting on July 29, 2021
    PJSC RusHydro (ticker symbol: MOEX, LSE: HYDR; OTCQX: RSHYY) announces that the Company's Board of Directors held a meeting in absentia on July 29, 2021.
  • Into the Audit Committee under the RusHydro Board of Directors, the following be elected:
    Member of the RusHydro Board of Directors, Chairman of the Association "NP Market Council" Management Board.
  • Into the HR and Remunerations (Nominations) Committee under the RusHydro Board of Directors, the following be elected:
    Member of the RusHydro Board of Directors, Chairman of the Association "NP Market Council" Management Board.
  • Into the Investment Committee under the RusHydro Board of Directors, the following be elected:
    Member of the RusHydro Board of Directors, Chairman of the Association "NP Market Council" Management Board.

Exagen Appoints Ana Hooker to Board of Directors

Articles, Board of directors, Business law, Committees, Corporate law, NASDAQ, Business
Friday, July 30, 2021 - 1:25pm

SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional independent member to its Board of Directors, effective July 29, 2021.

Key Points: 
  • SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional independent member to its Board of Directors, effective July 29, 2021.
  • We are excited to welcome Ms. Hooker to our Board of Directors, said Ron Rocca, Exagens President and Chief Executive Officer.
  • Exagen has a world-class laboratory, a robust pipeline and I look forward to working with the executive leadership team and board of directors, as the Company continues to execute on its compelling mission and growth strategy.
  • Ana Hooker has served as the Senior Vice President, Operations of Exact Sciences Corporation, a molecular diagnostics company, since July 2015.

Benefitfocus Names John Park to Board of Directors

Articles, Committees, Corporate law, Business, Corporate governance, Auditing, Board of directors, Business law, Audit committee
Thursday, July 29, 2021 - 9:05pm

CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, has expanded the Benefitfocus Board of Directors by one seat and appointed John J.

Key Points: 
  • CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, has expanded the Benefitfocus Board of Directors by one seat and appointed John J.
  • Park, an experienced senior finance and operations executive, to fill the new seat as an independent director, effective August 3.
  • Park will serve on the Boards audit committee and chair its compensation and talent committee.
  • I am excited to join the board of Benefitfocus and help guide its strategic path forward.

Columbia Financial, Inc. Announces the Appointment of Daria Torres to its Board of Directors

Articles, Business, Board of directors, Business law, Committees, Corporate law, McKinsey & Company, Non-executive director, Columbia University
Thursday, July 29, 2021 - 5:44pm

Ms. Torres appointment brings the Company's total number of directors to ten, nine of whom are independent non-executive directors.

Key Points: 
  • Ms. Torres appointment brings the Company's total number of directors to ten, nine of whom are independent non-executive directors.
  • Ms. Torres has more than 20 years of experience as a strategy consultant and advisor to CEOs, boards and executive teams.
  • Prior to founding Walls Torres Group, Ms. Torres served as a McKinsey & Company engagement manager and Lockheed Martin systems engineer.
  • Said Thomas J. Kemly, President and CEO of Columbia Financial and Columbia Bank, We are thrilled to welcome Ms. Torres to the Boards of Directors of Columbia Financial and Columbia Bank.

Prospect Capital Funds $202 Million in Senior Secured Floating Rate Term Loans to Progrexion  

Money, Finance, Loans, Economy, Property law, Bankruptcy, Business law, Credit, Lien, Second lien loan, H.I.G. Capital
Thursday, July 29, 2021 - 12:00pm

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect) announced today that Prospect has funded total commitments of $202 million,comprised of a$49 million first lien senior secured floating rate term loan and a$153 million second lien senior secured floating rate term loan to support the refinancing of PGX Holdings, Inc. (Progrexion) a portfolio company of H.I.G.

Key Points: 
  • NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (Prospect) announced today that Prospect has funded total commitments of $202 million,comprised of a$49 million first lien senior secured floating rate term loan and a$153 million second lien senior secured floating rate term loan to support the refinancing of PGX Holdings, Inc. (Progrexion) a portfolio company of H.I.G.
  • This transaction marks the 12th financing for Progrexion since H.I.G.s acquisition in 2010," said Elliot Maluth, Managing Director of H.I.G.
  • Prospect Capital Corporation ( www.prospectcap.com ) is a business development company that focuses on lending to and investing in private businesses.
  • Prospect has elected to be treated as a business development company under the Investment Company Act of 1940 (1940 Act).

Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board

Health, Infectious diseases, Other Science, Research, Science, Pharmaceutical, Biotechnology, Articles, Board of directors, Business law, Committees, Corporate law, Business
Friday, July 30, 2021 - 2:00pm

Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board of Directors.

Key Points: 
  • Virpax Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board of Directors.
  • I am pleased that we are adding two such highly knowledgeable professionals to our Board of Directors.
  • Each of them has valuable experience and we look forward to their contributions, commented Virpax Chairman and Chief Executive Officer Anthony P. Mack.
  • He currently serves as Chairman of the Board of Trustees for Lincoln University and serves on the executive committee of the Board at the National Sales Network.

Association of Corporate Counsel Names UnitedLex a 2021 Value Champion

Professional services, Data management, Other Professional Services, Technology, Legal, Other Technology, Consulting, Articles, Employment, Labor, Legal professions, Business law, Association of Corporate Counsel, General counsel, Lawyer, Corporation
Thursday, July 29, 2021 - 2:37pm

UnitedLex , a leading technology and legal services company, has been recognized as a 2021 Association of Corporate Counsel Value Champion.

Key Points: 
  • UnitedLex , a leading technology and legal services company, has been recognized as a 2021 Association of Corporate Counsel Value Champion.
  • Data is essential to business value, collaboration, and team performance within DXC Legal, which is comprised of dedicated UnitedLex professionals as part of an innovative model.
  • Since 2012, the ACC Value Champions program highlights corporate law departments that innovate to optimize legal service delivery for corporations.
  • "We are delighted to be share this prestigious honor and stand alongside UnitedLex and the many distinguished companies that were recognized by the Association of Corporate Counsel," said Bill Deckelman, Executive Vice President and General Counsel, DXC.

Comtech Telecommunications Corp. Awarded Multi-Million Dollar Order for New Ground Station Development Contract

Semiconductor, Aerospace, Security, Manufacturing, Satellite, Audio, Video, Transport, Other Technology, Telecommunications, Software, Networks, Internet, Hardware, Electronic design automation, Logistics, Supply chain management, VoIP, Technology, Mobile, Wireless, Business law, Product management, Turnkey
Thursday, July 29, 2021 - 2:00pm

We are pleased that our long-term customer continues to rely on Comtech for yet another ground station development contract, said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp.

Key Points: 
  • We are pleased that our long-term customer continues to rely on Comtech for yet another ground station development contract, said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp.
  • The contract was awarded to Comtechs Space and Component Technology (SCT) division, which specializes in providing ground station services in the form of turnkey site development, infrastructure, operations and maintenance of several range tracking stations in the South Pacific.
  • Using the concepts of product families and platform-based product development to increase variety, shorten lead-times and reduce costs without compromising system performance, SCT provides turnkey ground station solutions for both launch vehicle and satellite tracking.
  • Comtech Telecommunications Corp. is a leading provider of next-generation 911 emergency systems and critical wireless communication technologies to commercial and government customers around the world.

MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market

Articles, Business law, Board of directors, Committees, Corporate law
Friday, July 30, 2021 - 4:05am

GAITHERSBURG, Md., July 30, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the pricing of its upsized offering of 13,500,000 shares of common stock at an initial offering price of US$13.00 per share (the "Offering").

Key Points: 
  • The closing of the Offering is expected to occur on August 3, 2021, subject to customary closing conditions.
  • Cowen, Stifel and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters for the Offering.
  • In connection with the Offering, MaxCyte has adopted amended and restated Bylaws (the "Bylaws"), which will take effect immediately before the closing of the Offering.
  • A copy of the Bylaws will be publicly filed and made available to both Nasdaq and AIM shareholders upon closing of the Offering.

MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market

Articles, Business law, Board of directors, Committees, Corporate law
Friday, July 30, 2021 - 3:42am

The closing of the Offering is expected to occur on August 3, 2021, subject to customary closing conditions.

Key Points: 
  • The closing of the Offering is expected to occur on August 3, 2021, subject to customary closing conditions.
  • Cowen, Stifel and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters for the Offering.
  • In connection with the Offering, MaxCyte has adopted amended and restated Bylaws (the "Bylaws"), which will take effect immediately before the closing of the Offering.
  • A copy of the Bylaws will be publicly filed and made available to both Nasdaq and AIM shareholders upon closing of the Offering.